Sanofi India Limited — Board Meeting, 14-05-2025: Outcome of Board Meeting

Sanofi India has announced a board meeting approving the financial results for the quarter, reporting net sales growth of 4% and operating profit rising 27% to ₹162 Cr. Profit after tax from continuing operations increased to ₹119.5 Cr, with earnings per share at ₹51.89. Growth was led by the launch of Soliqua®, boosting its diabetes portfolio, along with improved cost efficiencies. The company remains focused on its ‘India for India’ strategy, driving innovation, operational efficiencies, and expanding access to premium products. Strategic initiatives and solid operational momentum underpin its outlook.